Trans fat involvement in cardiovascular disease

Molecular Nutrition and Food Research

Volumn 56, Issue 7, 2012, Pages 1090-1096

  Ganguly, Riya ^a,b   Pierce, Grant N ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Atherosclerosis; Fatty acid; Heart disease; Nutrition; Trans fat

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; LIPID; LIPOPROTEIN; TRANS FATTY ACID;

ADIPOCYTE; ANIMAL; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIET; FOOD HANDLING; HUMAN; IMMUNOLOGY; MEMBRANE FLUIDITY; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RISK; VASCULAR ENDOTHELIUM;

ADIPOCYTES; ADIPOKINES; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; CYTOKINES; DIET; ENDOTHELIUM, VASCULAR; FOOD HANDLING; HUMANS; LIPIDS; LIPOPROTEINS; MEMBRANE FLUIDITY; RISK; TRANS FATTY ACIDS;

ANIMALIA;

EID: 84863550850     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100700     Document Type: Review

References (68)

1. Wilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M., et al., Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97, 1837-1847.
2. Eilat-Adar, S., Goldbourt, U., Nutritional recommendations for preventing coronary heart disease in women: evidence concerning whole foods and supplements. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 459-466.
3. Badimon, L., Vilahur, G., Padro, T., Nutraceuticals and atherosclerosis: human trials. Cardiovasc. Ther. 2010, 28, 202-215.
4. Houston, M. C., The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther. Adv. Cardiovasc. Dis. 2010, 4, 165-183.
5. Kant, A. K., Dietary patterns: biomarkers and chronic disease risk. Appl. Physiol. Nutr. Metab. 2010, 35, 199-206.
6. Flock, M. R., Kris-Etherton, P. M., Dietary Guidelines for Americans 2010: implications for cardiovascular disease. Curr. Atheroscler. Rep. 2011, 136, 499-507.
7. Mente, A., de Koning, L., Shannon H. S., Anand, S. S., A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 2009, 169, 659-669.
8. Marchand, V., Trans fats: what physicians should know. Paediatr. Child Health 2010, 15, 373-378.
9. Remig, V., Franklin, B., Margolis, S., Kostas, G et al., Trans fats in America: a review of their use, consumption, health implications, and regulation. J. Am. Diet Assoc. 2010, 110, 585-592.
10. Allison, D. B., Egan, S. K., Barraj, L. M., Caughman, C., et al., Estimated intakes of trans fatty and other fatty acids in the US population. J. Am. Diet Assoc. 1999, 99, 166-174; quiz 175-176.
11. Bassett, C. M., Edel, A. L., Patenaude, A. F., McCullough, R. S., et al., Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J. Nutr. 2010, 140, 18-24.
12. Micha, R., Mozaffarian, D., Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79, 147-152.
13. Willett, W. C., Stampfer, M. J., Manson, J. E., Colditz, G. A., et al., Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341, 581-585.
14. Erkkilä, A. T., Booth, S. L., Hu, F. B, Jacques, P. F., et al., Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. Eur. J. Clin. Nutr. 2005, 59, 196-204.
15. Hu, F. B., Willett, W. C., Optimal diets for prevention of coronary heart disease. JAMA 2002, 288, 2569-2578.
16. Singh, R. B., Niaz, M. A., Ghosh, S., Beegom R., et al., Association of trans fatty acids (vegetable ghee) and clarified butter (Indian ghee) intake with higher risk of coronary artery disease in rural and urban populations with low fat consumption. Int. J. Cardiol. 1996, 56, 289-298; discussion 299-300.
17. Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm E., et al., Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 1997, 337, 1491-1499.
18. Watts, G. F., Lewis, B., Jackson, P., Burke, V., et al., Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Can. J. Cardiol. 1995, 11, 110G-114G.
19. Sébédio, J. L., Vermunt, S. H., Chardigny, J. M., Beaufrère, B., et al., The effect of dietary trans alpha-linolenic acid on plasma lipids and platelet fatty acid composition: the TransLinE study. Eur. J. Clin. Nutr. 2000, 54, 104-113.
20. Kwiterovich, P. O., Jr., The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis. J. Am. Diet Assoc. 1997, 97, S31-S41.
21. Matthan, N. R., Welty, F. K., Barrett, P. H., Harausz, C., et al., Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1092-1097.
22. Dlouhý, P., Tvrzická, E., Stanková, B., Vecka, M., et al., Higher content of 18:1 trans fatty acids in subcutaneous fat of persons with coronarographically documented atherosclerosis of the coronary arteries. Ann. Nutr. Metab. 2003, 47, 302-305.
23. Clifton, P. M., Keogh, J. B., Noakes, M., Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J. Nutr. 2004, 134, 874-879.
24. Stachowska, E., Dołegowska, B., Chlubek, D., Wesołowska, T., et al., Dietary trans fatty acids and composition of human atheromatous plaques. Eur. J. Nutr. 2004, 43, 313-318.
25. van de Vijver, L. P., van Poppel, G., van Houwelingen, A., Kruyssen, D. A., et al., Trans unsaturated fatty acids in plasma phospholipids and coronary heart disease: a case-control study. Atherosclerosis 1996, 126, 155-161.
26. Leth, T., Jensen, H. G., Mikkelsen, A. A., A. Bysted, The effect of the regulation on trans fatty acid content in Danish food. Atheroscler. Suppl. 2006, 7, 53-56.
27. Kritchevsky, D., Davidson, L. M., Weight, M., Kriek, N. P., et al., Effect of trans-unsaturated fats on experimental atherosclerosis in vervet monkeys. Atherosclerosis 1984, 51, 123-133.
28. Ruttenberg, H., Davidson, L. M., Little, N. A., Klurfeld, D. M., et al., Influence of trans unsaturated fats on experimental atherosclerosis in rabbits. J. Nutr. 1983, 113, 835-844.
29. Matthan, N. R., Cianflone, K., Lichtenstein, A. H., Ausman, L. M., Jauhiainen, M., et al., Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women. J. Lipid Res. 2001, 42, 1841-1848.
30. Matthan, N. R., Ausman, L. M., Lichtenstein, A. H., P. J., Jones ., Hydrogenated fat consumption affects cholesterol synthesis in moderately hypercholesterolemic women. J. Lipid Res. 2000, 41, 834-839.
31. Meir, K. S., Leitersdorf, E., Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb. Vasc. Biol. 2004, 24, 1006-1014.
32. Bassett, C. M. C., McCullough, R. S., Edel, A. L., Maddaford, T. G., et al., Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 2009, 58, 1802-1808.
33. Colandre, M. E., Diez, R. S., Bernal, C. A., Metabolic effects of trans fatty acids on an experimental dietary model. Br. J. Nutr. 2003, 89, 631-639.
34. Kritchevsky, D., Trans fatty acid effects in experimental atherosclerosis. Fed. Proc. 1982, 41, 2813-2817.
35. Mureddu, G. F., Brandimarte, F., De Luca, L., High-density lipoprotein levels and risk of cardiovascular events: a review. J. Cardiovasc. Med. (Hagerstown) 2011.
36. Adams T. H., Walzem R. L., Smith D. R., Tseng, S., et al., Hamburger high in total, saturated and trans-fatty acids decreases HDL cholesterol and LDL particle diameter, and increases TAG, in mildly hypercholesterolaemic men. Br. J. Nutr. 2010, 103, 91-98.
37. Dashti, N., Feng, Q., Freeman, M. R., Gandhi, M., et al., Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells. J. Nutr. 2002, 132, 2651-2659.
38. Mitmesser, S. H., Carr, T. P., Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells. J. Nutr. Biochem. 2005, 16, 178-183.
39. Mauger, J. F., Lichtenstein, A. H., Ausman, L. M., Jalbert, S. M., et al., Effect of different forms of dietary hydrogenated fats on LDL particle size. Am. J. Clin. Nutr. 2003, 78, 370-375.
40. Maskrey, B. H., Megson, I. L., Whitfield, P. D., Ross, A. G., Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1001-1006.
41. Ait-Oufella, H., Taleb, S., Mallat, Z., Tedgui, A., Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 969-979.
42. DeClercq, V., Zahradka, P., Taylor, C. G., Dietary t10, c12-CLA but not c9, t11 CLA reduces adipocyte size in the absence of changes in the adipose renin-angiotensin system in fa/fa Zucker rats. Lipids 2010, 45, 1025-1033.
43. Obara, N., Fukushima, K., Ueno, Y., Wakui, Y., et al., Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J. Hepatol. 2010, 53, 326-334.
44. Kleinbongard, P., Heusch, G., Schulz, R., TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol. Ther. 2010, 127, 295-314.
45. Goua, M., Mulgrew, S., Frank, J., Rees, D., Sneddon, A. A., et al., Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB? Prostaglandins Leukot. Essent Fatty Acids 2008, 78, 33-43.
46. Blewett, H. J., Gerdung, C. A., Ruth, M. R., Proctor, S. D., et al., Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br. J. Nutr. 2009, 102, 526-536.
47. Siddiqui, R. A., Harvey, K. A., Ruzmetov, N., Miller, S. J., et al., n-3 fatty acids prevent whereas trans-fatty acids induce vascular inflammation and sudden cardiac death. Br. J. Nutr. 2009, 102, 1811-1819.
48. Park, S., Park, Y., Effects of dietary fish oil and trans fat on rat aorta histopathology and cardiovascular risk markers. Nutr. Res. Pract. 2009, 3, 102-107.
49. Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., et al., Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14, 561-566.
50. Huang, Z., Wang, B., Pace, R. D., Yoon, S., Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats. Nutr. Res. 2009, 29, 206-212.
51. McCaffrey, T. A., TGF-beta signaling in atherosclerosis and restenosis. Front Biosci. (Schol Ed) 2009, 1, 236-245.
52. Kohli, R., Kirby, M., Xanthakos, S. A., Softic, S., et al., High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010, 52, 934-944.
53. Fernandes, G., Dietary lipids and risk of autoimmune disease. Clin. Immunol. Immunopathol. 1994, 72, 193-197.
54. Baer D. J., Judd J. T., Clevidence, B. A., Tracy, R. P., Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 2004, 79, 969-973.
55. Smit, L. A., Katan, M. B., Wanders, A. J., Basu, S., et al., A high intake of trans fatty acids has little effect on markers of inflammation and oxidative stress in humans. J. Nutr. 2011, 141, 1673-1678.
56. Stryjecki, C., Mutch, D. M., Fatty acid-gene interactions, adipokines and obesity. Eur. J. Clin. Nutr. 2011, 65, 285-297.
57. Saravanan, N., Haseeb, A., Ehtesham, N. Z., Ghafoorunissa, Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur. J. Endocrinol. 2005, 153, 159-165.
58. Bryk, D., Zapolska-Downar, D., Malecki, M., Hajdukiewicz, K., et al., Trans fatty acids induce a proinflammatory response in endothelial cells through ROS-dependent nuclear factor-kappaB activation. J. Physiol. Pharmacol. 2011, 62, 229-238.
59. Lopez-Garcia, E., Schulze, M. B., Meigs, J. B., Manson, J. E., et al., Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005, 135, 562-566.
60. Feller, S. E., Gawrisch, K., Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin. Curr. Opin. Struct. Biol. 2005, 15, 416-422.
61. Roach, C., Feller, S. E., Ward, J. A., Shaikh, S. R., et al., Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochemistry 2004, 43, 6344-6351.
62. Demel, R. A., Jansen, J. W., van Dijck, P. W., van Deenen, L. L., The preferential interaction of cholesterol with different classes of phospholipids. Biochim. Biophys. Acta 1977, 465, 1-10.
63. Van Dijck, P. W., De Kruijff, B., Van Deenen, L. L., De Gier, J., et al., The preference of cholesterol for phosphatidylcholine in mixed phosphatidylcholine-phosphatidylethanolamine bilayers. Biochim. Biophys. Acta 1976, 455, 576-587.
64. Niu, S. L., Mitchell, D. C., Litman, B. J., Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005, 44, 4458-4465.
65. Engelhard, V. H., Esko, J. D., Storm, D. R., Glaser, M., Modification of adenylate cyclase activity in LM cells by manipulation of the membrane phospholipid composition in vivo. Proc. Natl. Acad. Sci. U. S. A. 1976, 73, 4482-4486.
66. Kummerow, F. A., Zhou, Q., Mahfouz, M. M., Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am. J. Clin. Nutr. 1999, 70, 832-838.
67. Csordas, A., Schauenstein, K., Structure- and configuration-dependent effects of C18 unsaturated fatty acids on the chicken and sheep erythrocyte membrane. Biochim. Biophys. Acta 1984, 769, 571-577.
68. Bassett, C. M. C., McCullough, R. S., Edel, A. L., Patenaude, A., et al., The α-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. Am. J. Physiol. 2011, epub online. DOI:10.1152/ajpheart.00958.2010.